Synthetic CoM Operons for Oxidation-Stable Antioxidant Biosynthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The complete biosynthesis of coenzyme M (CoM) has not been demonstrated, limiting its efficient production and use as an antioxidant, particularly in aerobic organisms, where chemically synthesized CoM is sensitive to oxidation.

Innovation Solution

Polynucleotides encoding coenzyme M synthase (ComF) operably linked with heterologous regulatory elements, such as taurine-pyruvate aminotransferase, are introduced into cells to biosynthesize CoM, utilizing metabolic pathways involving sulfoacetaldehyde production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemically synthesized CoM is used, then production efficiency is improved, but stability against oxidation deteriorates

Engineering Contradiction:
Improveproduction efficiencyVSAvoidstability against oxidation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces chemical synthesis methods with biological synthesis methods by introducing heterologous genes (comF, comE, comD) into host organisms. This substitution enables in vivo production of CoM through metabolic pathways, achieving both high production efficiency and stability since the biosynthesized CoM is produced within the protective cellular environment and can be deployed at the site of oxidative damage.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If complete biosynthesis of CoM is achieved, then stability and in vivo deployment are improved, but device complexity increases

Engineering Contradiction:
ImprovestabilityVSAvoidcomplexity of biosynthetic pathway
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent divides the CoM biosynthesis pathway into discrete functional modules encoded by separate genes (comF for cysteate synthase, comE for sulfopyruvate decarboxylase, comD for sulfoacetaldehyde acetyltransferase). These modular genetic units can be independently cloned, expressed, and optimized in host organisms, reducing the complexity of implementing the complete biosynthetic pathway while maintaining stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses universal promoter elements and regulatory sequences that can drive expression of the heterologous CoM biosynthesis genes in diverse host organisms including bacteria, yeast, and plant cells. This universality allows the same biosynthetic pathway to be deployed across multiple species without requiring organism-specific customization, thereby reducing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances CoM production and utilization as an antioxidant, improving growth and resistance to oxidative stress in aerobic organisms like E. coli and plants.

Implementation Method 1

Polynucleotides encoding coenzyme M synthase (ComF) operably linked with heterologous regulatory elements, such as taurine-pyruvate aminotransferase, are introduced into cells to biosynthesize CoM, utilizing metabolic pathways involving sulfoacetaldehyde production.

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

Coenzyme M, also known as 2-mercaptoethanesulfonate (MESNA), is an antioxidant that can be chemically synthesized, but is sensitive to oxidation in the environment, which limits the use of chemically synthesized CoM.

Methodology Applied
Scientific EffectAntioxidant activity: Redox Reactions

Data Source

PatentUS20250382589A1Synthetic operons for the production of 2-mercaptoethane sulfonate (coenzyme m) and methods of using the same
Publication Date: 2025.12.18 BOARD OF RGT UNIV OF NEBRASKA
  • US20250382589A1 patent drawing
  • US20250382589A1 patent drawing
  • US20250382589A1 patent drawing

AI summary

Disclosed herein are polynucleotides comprising sequences encoding coenzyme M synthase (ComF) linked to a heterologous regulatory element and methods of using the same. The polynucleotides may comprise synthetic operons comprising additional sequences encoding enzymes, e.g., a taurine-pyruvate aminotransferase, a sulfoacetaldehyde acetyl transferase, or a sulfopyruvate decarboxylase. Also disclosed herein are recombinant prokaryotic cells, e.g., recombinant bacterial, e.g., E. coli, or archaeal cells, e.g., Methanosarcina acetivorans with improved tolerance to oxidative stress.